What can Actigraphy Add to the Concept of Labschool Design in Clinical Trials?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|22|2434-2442

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.22, 2010-07, pp. : 2434-2442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unequal randomisation can improve the efficiency of clinical trials

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 282, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?

By Dhanda Ashwin D.   Creed Tom J.   Greenwood Rosemary   Sands Bruce E.   Probert Christopher S.  

Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. : 2056-2062

Blackwell Publishing

Access to resources Recommend Favorite

CCR1 Antagonists: What Have We Learned From Clinical Trials

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 13, 2010-09 ,pp. : 1268-1277

Bentham Science Publishers

Access to resources Recommend Favorite

What Can Consumer Adverse Drug Reaction Reporting Add to Existing Health Professional-Based Systems?: Focus on the Developing World

By Fernandopulle R.B.M.   Weerasuriya K.  

Drug Safety, Vol. 26, Iss. 4, 2003-01 ,pp. : 219-225

Adis International

Access to resources Recommend Favorite

An Adaptive Optimal Design for the Emax Model and Its Application in Clinical Trials

By Leonov Sergei  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 2, 2009-03 ,pp. : 360-385

Taylor & Francis Ltd

Access to resources Recommend Favorite